Covid Vaccine In Kids Less Effective Against Omicron Vs Delta But Ward Off Severe Illness From Both Study

The Pfizer / BioNTech vaccine for COVID-19 provided less protection against the omicron variant of the delta strain in children, but protects against both serious diseases, according to a study published in the New England Journal of Medicine on Wednesday. The report said vaccinating children ages 5 to 11 reduced COVID-19 treatment by more than two-thirds during the micron increase and protected against serious illness. The researchers found that the vaccine also reduced COVID-19-related hospitalizations in adolescents aged 12-18 years and strongly protected against serious diseases, according to the study led by Dr. Adrienne Randolph, MD, M.Sc, at Boston Children’s Hospital. with the Centers for Disease Control and Prevention. THE COVID PANDEMIC PROVIDES TO THE BASIC MEDICAL SUPPORT COMMUNITY “The reason a child gets a COVID-19 vaccine is to prevent serious complications of SARS-CoV-2 infection, including hospitalization,” Randolph said in a press release. child and adult holding red heart with stethoscope, heart health, health insurance concept (Credit: iStock) “These data show that vaccination significantly reduces this risk in children aged 5 to 11 years. And while vaccination provided lower protection for adolescents against deltoid’s micron hospitalization, it prevented critical illness from both variants.” OMICRON BA.2 VARIATION NOW WORLDWIDE OFFERED The study looked at data obtained from 1185 patients treated with Covid-19 aged 5 to 18 years and 1627 control patients of similar age who were not diagnosed with Covid-19 in 31 pediatric hospitals in 23 states from July 2021 to February. of 2022. The researchers found that overall, 88 percent of COVID-19 patients were unvaccinated and 25 percent needed life support measures. They looked further to find that 92 percent of children aged 5-11 years treated with COVID-19 had not been vaccinated. Sixteen percent of them were considered seriously ill and needed life support interventions such as intubation. Of that group, 90 percent were unvaccinated, according to the study.
OMIKRON SUB-PARACTIC BA.2: THE HEALTH SERVICES CALL IT “CONCERN CHANGE” In the group of adolescents aged 12-18 years who were hospitalized with COVID-19 infections, 87 percent were vaccinated. The study reported that twenty-seven percent were seriously ill and of these, 93 percent were unvaccinated. Two children died, the statement said.
One researcher pushed for the reopening of schools to mitigate the deteriorating mental health consequences among the affected children. (iStock) According to the study, two doses of the Pfizer-BioNTech vaccine were 68 percent effective in preventing omicron treatment in the 5-11 year old group. The researchers said in a statement that since this age group had only recently become eligible for the vaccine, they could not effectively estimate the number of critical illnesses individually.
The study authors also reported that in the 12-18 year old group, the vaccine was 92 percent effective against delta-type hospitalization, while it dropped to 40 percent effective against the micron variant. Despite the decline, the study authors said the vaccine was 96 percent effective in preventing severe cases during the delta period and 79 percent during the micron wave. CLICK HERE TO RECEIVE THE FOX NEWS APPLICATION Despite the vaccines currently available for children and adolescents, the researchers said parents still hesitate to get vaccinated as of March 16, with only 57 percent of children 12 to 17 and 27 percent of children 5 to 11-year-olds had received two doses of the vaccine. , according to a report citing CDC data collected by the American Academy of Pediatrics. An Israeli health worker administers a dose of the Pfizer / BioNTech Covid-19 vaccine to a student at al-Manahel School in the village of Majdal Shams in the Golan Heights annexed by Israel on December 12, 2021. (JALAA MAREY / AFP via Getty Images) “We hope our findings will help parents make the decision to vaccinate their children and adolescents against COVID-19,” Randolph said in a statement. “The benefits clearly outweigh the risks, as serious childhood infections can have long-term consequences.”